COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes

Amber Salter, Anne H. Cross, Gary R. Cutter, Robert J. Fox, David K.B. Li, Bruce Bebo, June Halper, Pamela Kanellis, Kottil Rammohan, Scott D. Newsome

Research output: Contribution to journalLetterpeer-review

2 Scopus citations


Women with multiple sclerosis (MS) are often of childbearing age. Thirty-six women with MS who were pregnant (n = 27) or within 6 weeks postpartum (n = 9) were reported in the North American COViMS registry and their COVID-19 outcomes were described. One pregnant and one postpartum woman were hospitalized. No deaths occurred. To compare COVID-19 clinical outcomes in pregnant and postpartum females with females who were not pregnant or postpartum, a 1:2 propensity score match was performed. While not powered to detect small differences, it was reassuring that no increased risks for those with MS who were pregnant/postpartum were revealed.

Original languageEnglish
Article number104028
JournalMultiple Sclerosis and Related Disorders
StatePublished - Sep 2022


  • COVID-19
  • Multiple sclerosis
  • Postpartum
  • Pregnancy
  • SARS-CoV-2


Dive into the research topics of 'COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes'. Together they form a unique fingerprint.

Cite this